Member list of Oslo Cancer Cluster

Below you find a list of all members of Oslo Cancer Cluster in alphabetical order.

Results 1 - 20 out of 93 displayed.
 
Sort direction:
Sort direction:
1  2  3  4  5 »
AbbVie AS   
Oslo, Norway
AbbVie is a research-based biopharmaceutical company. The company's mission is to develop and market advanced therapies in the areas of hepatitis C (HCV), neuroscience, immunology, oncology, etc. AbbVie AS is the sales and marketing arm of AbbVie Inc, USA.
AdjuTec Pharma AS   
Oslo, Norway
AdjuTec Pharma AS is a developer of antibiotic resistance breakers intended to meet the imminent threat to modern medicine of antimicrobial resistance (AMR). The company portfolio includes inhibitors for the treatment of resistant fungal infections and G-bacteria.
Akershus University Hospital HF   
Akershus universitetssykehus HF
Lørenskog, Norway
Akershus University Hospital (Ahus) provides treatments that safeguard and promotes patients' health. The hospital delivers specialists in somatic health care, mental health, and substance abuse.
Algorithmiq Ltd   
Helsinki, Finland
Algorithmiq is a company developing advanced algorithms to solve complex problems in life sciences. The company's mission is to revolutionise life sciences by exploiting the potential of quantum computing to solve currently inaccessible problems.
Alv B AS   
Oslo, Norway
Alv B is a Oslo based biotech company developing immunotherapy, as well as other experimental cancer therapeutics for dogs and cats. The company's products include Alvacan 1000 & 4000, Alvacan XO, etc.
Amgen Norge   
Oslo, Norway
Amgen AB is active in clinical trials, medical information and scientific projects. The marketing department is responsible for disseminating information about marketed drugs for health professionals. Amgen has a broad portfolio of biotechnological drugs in the fields of therapy oncology, hematology, nephrology, osteoporosis and cardiology.
Antegenes OÜ   
Tartu, Estonia
Antegenes OÜ is a biotechnology and healthcare company developing and implementing innovative genetic tests based on polygenic risk score technology to enable personalized prevention of common cancers. The company's products include AnteBC, AntePC, AnteCRC, etc.
APIM Therapeutics AS   
Rissa, Norway
APIM Therapeutics AS is a venture-capital financed oncology biotech company developing a pipeline of peptide drugs that target proliferating cell nuclear antigen (PCNA)-dependent stress responses in cancer cells. The company's lead drug, ATX-101 is currently in clinical development in ovarian cancer (phase 1b/2a) and sarcoma (phase 2).
Arctic Pharma AS   
Oslo, Norway
Arctic Pharma AS is engaged in developing anti-cancer drugs for glycolytic cancers by exploiting the cancer cells and their peculiar metabolic features. The company is focused on developing anti-cancer drugs by exploiting the “sweet tooth” of cancer cells. Arctic Pharma has designed inhibitors that can directly target key enzymes that are upregulated in cancer cell metabolism.
Astellas Pharma   
Asker, Norway
Astellas Pharma is a research-oriented global pharmaceutical company operating in about 50 countries with a focus on ethical pharmaceuticals. The company focuses on the areas like urology, immunology, infectious diseases, oncology, neuroscience, etc.
AstraZeneca AS   
Oslo, Norway
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & Immunology
Augere Medical AS   
Oslo, Norway
Augere Medical is a startup that develops cutting-edge AI to medical devices. The company's goal is to reduce human variability in the inspection of diagnostic videos, and the patent-pending technology allows the system to take time and context into account when video is analysed in real-time. The first product developed is for colorectal cancer detection and prevention.
Bayer AS   
Oslo, Norway
Bayer AS develop new molecules for use in innovative products and solutions to contribute to better health for people, animals and plants. Bayer's activities in research and development are based on a deep understanding of the biochemical processes in living organisms.
Bio-ME AS   
Oslo, Norway
Bio-ME AS is a microbiome research platform intended to make a new standard for gut microbiome analysis. The company offers a range of proprietary solutions to support research and development of microbiome-based information.
Birk Venture   
Oslo, Norway
Birk Venture is a venture capital firm specializing in early stage. The firm invests in small size and start-up companies with a unique technology. The company exclusively invests in the life science industry with a special focus on pharmaceuticals, biotechnology, diagnostics, medical devices and instruments, and consumer health.
Bristol Myers Squibb Norway   
Lysaker, Norway
Bristol-Myers Squibb operates as a biopharmaceutical company, which engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. The company in Norway focuses on sales and services and also supports hospital clown.
Cancer Registry of Norway (Kreftregisteret)   
Oslo, Norway
The Cancer Registry of Norway was established to collect data and produce statistics of the cancer prevalence in Norway, and has a research activity. The Cancer Registry is also responsible for the national screening programmes: Breast Cancer Screening Programme and Cervical Cancer Screening Programme. The goal of which is to prevent cancer death by discovering cancer or pre cancerous lesions as early as possible.
Canica AS   
Oslo, Norway
Canica AS is a holding and investment company based in Oslo, Norway. Founded in 1985, Canica AS is focused on real estate, consumer durable and manufacturing investing. Through its operations it seeks long-term business ownership and value. The health sector is one example of what Canica's investment portfolio consists of and includes both direct and indirect investments.
Cellmover AS   
Oslo, Norway
Cellmover AS develop immunotherapeutic products directed at treatment of cancer. The company specifically design products to enhance survival, activity, and targeting of immune cells used for cell therapy.
Concilium Search   
London, United Kingdom
Concilium Search is a staffing and recruiting firm that offers interim contracts, executive search, and strategic recruitment. The company is specialising in the Life-Sciences, Technology, Industrials and Management Consulting industries.

1  2  3  4  5 »
© Biotechgate by Venture Valuation